Prosthetic Use, Mobility and Daily Functioning (ProMob)

October 10, 2022 updated by: Oslo Metropolitan University
The goal of the project is to explore which elements of rehabilitation that influence mobility in new and experienced unilateral lower-limb amputees.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Both new and experienced unilateral lower limb amputees (LLA) describe difficulties when ambulating intentionally and independently from one place to another using prosthesis. In LLA, this decreased ability to mobilize affect daily functioning and may result in low activity-levels, impeded social participation and reduced health-related quality of life.

Both primary and secondary rehabilitation of LLA have implications for functional mobility. The consensus among health professionals is that LLA should train to improve their ability to ambulate. However, knowledge from research regarding which elements that constitute effective training and how systematic exercise affects body structures, functions, activity and participation in lower limb amputees, is limited.

There also is a lack of knowledge of how prosthetic users endure and process the challenges regarding mobility, how they adapt to the use of their prosthesis, how safe they are ambulating using the prosthesis, and how pain and psychosocial issues affect their perceived health and mobility.

The aim of this Ph.D.-project is to explore how a period of semi-standardized individualized rehabilitation originating from an evidence-based approach, affect the functional mobility of both new and experienced LLA, and how LLA process the loss of a limb and challenges during ambulation.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0130
        • OsloMet
    • Viken
      • Halden, Viken, Norway, 1765
        • Unicare Bakke

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria for experienced users of prosthesis - intervention group:

  • Unilaterally amputated (above the ankle joint / under the hip joint)
  • Minimum 12 months since amputation
  • Have a well-adapted prosthesis before baseline measurements
  • Not attended an organized, regular training program for the last 6 months
  • Uses the prosthesis on a daily basis
  • Participation approved by physician

Inclusion Criteria for experienced users of prosthesis - control group:

  • Unilaterally amputated (above the ankle joint / under the hip joint)
  • Minimum 12 months since amputation
  • Have a well-adapted prosthesis before baseline measurements
  • Daily use of the prosthesis
  • Not attended an organized, regular training program in the last 6 months
  • No participation in regular and systematic training between pre- and post-testing

Inclusion Criteria for new users of prosthesis:

  • Unilaterally amputated (above the ankle joint / under the hip joint)
  • No prior record of use of prosthesis
  • Participation approved by physician

Exclusion Criteria:

  • Bilaterally amputated over ankle joint
  • Lack of understanding of Norwegian language (oral, written)
  • Neurological disorders affecting gait function
  • Skin lesion or abrasion on the stump or remaining extremity affecting mobility and function
  • Other issues that complicate participation in a rehabilitation intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experienced LLA - intervention
Experienced lower-limb amputees that complete a 4-week semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.
Strength, flexibility, endurance, balance, mobility, (self-efficacy)
Experimental: Experienced LLA - controls
Experienced lower-limb amputees that will be tested with a 4-week interval. No intervention. This group will be matched to the group of experienced lower-limb amputees.
Strength, flexibility, endurance, balance, mobility, (self-efficacy)
Experimental: New LLA learning to use prosthesis
New lower-limb amputees that complete a 8-11 weeks semi-structured individualized rehabilitation regime with extensive testing before and after the intervention.
Strength, flexibility, endurance, balance, mobility, (self-efficacy)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prosthetic Limb Users Survey of Mobility (Plus-M) Short form - 12 items
Time Frame: 4-8 weeks
A questionnaire that measures different aspects of mobility in lower-limb amputees (LLA) using prosthesis. PLUS-M provide a score range from 17.5 to 76.6. High scores indicate better outcome.
4-8 weeks
The Amputee Mobility Predictor (AMP).
Time Frame: 4-8 weeks
The test is designed to measure mobility and ability to move with prosthesis (AMPPro) and without prosthesis (AMPNoPro). AMPPro provide a score range from 0-47. AMPNoPro provide a score range from 0-43. High scores indicate better outcome.
4-8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R) - psychosocial adjustment
Time Frame: 4-8 weeks

The questionnaire examines psychosocial processes involved in adapting to the prosthesis as well as specific needs when using prosthesis.

Psychosocial adjustment - general subscale, provide a score range from 1.0-4.0. High scores indicative of positive adjustment.

Psychosocial adjustment - social subscale, provide a score range from 1.0-4.0. High scores indicative of positive adjustment.

Psychosocial adjustment - adjustment to limitation subscale, provide a score range from 1.0-4.0. High scores indicative of positive adjustment.

4-8 weeks
Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R) - activity restriction scale
Time Frame: 4-8 weeks

The questionnaire examines psychosocial processes involved in adapting to the prosthesis as well as specific needs when using prosthesis.

Activity restriction scale, provide a score range from 0.0-2.0. High scores is indicative of activity restriction.

4-8 weeks
Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R) - satisfaction with prosthesis
Time Frame: 4-8 weeks

The questionnaire examines psychosocial processes involved in adapting to the prosthesis as well as specific needs when using prosthesis.

Satisfaction with prosthesis - aesthetic satisfaction subscale, provide a score range from 3-9. High scores is indicative of satisfaction with prosthesis.

Satisfaction with prosthesis - functional satisfaction subscale, provide a score range from 5-15. High scores is indicative of satisfaction with prosthesis.

4-8 weeks
Activities-Specific Balance Confidence scale (ABC)
Time Frame: 4-8 weeks
The questionnaire measures how confident LLA are in performing ADL without losing balance or becoming unsteady. ABC provide a score range from 0-64. High scores indicate better outcome.
4-8 weeks
EuroQoL 5L - health-related quality of life (EQ-5D-5L)
Time Frame: 4-8 weeks
Standardized generic instrument used to measure health outcomes and health-related quality of life. Each question provide a score range from 1-5. High scores indicate worse outcome.
4-8 weeks
Two-minute walk test (2WT)
Time Frame: 4-8 weeks
The test measures functional mobility and the distance covered in two minutes.
4-8 weeks
The L-Test of Functional Mobility (L-test)
Time Frame: 4-8 weeks
The test measures functional mobility and is designed specifically for LLA. The LLA walks as fast as possible in a 3 x 7 meter L-shaped walkway that requires change of direction both ways.
4-8 weeks
General Perceived Self-Efficacy Scale (GSE)
Time Frame: 4-8 weeks
Assesses self-efficacy when coping with challenging demands in life. GSE provide a score range from 10-40. High scores indicate better outcome.
4-8 weeks
Grip strength
Time Frame: 4-8 weeks
Grip strength as measured by hand dynamometer
4-8 weeks
Balance
Time Frame: 4-8 weeks
Postural balance measured as center of pressure excursion by insoles with pressure sensors and a gyroscope sensor.
4-8 weeks
Activity level
Time Frame: 4-8 weeks
Number of steps measured by an accelerometer
4-8 weeks
Gait characteristics - temporal parameters
Time Frame: 4-8 weeks
Gait characteristics measured in seconds by insoles with pressure sensors and gyroscope sensor
4-8 weeks
Gait characteristics - spatial parameters
Time Frame: 4-8 weeks
Gait characteristics measured in meters by insoles with pressure sensors and gyroscope sensor
4-8 weeks
Gait characteristics - ground reaction force Gait characteristics - ground reaction force
Time Frame: 4-8 weeks
Gait characteristics measured in Newton by insoles with pressure sensors and gyroscope sensor
4-8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Terje Gjøvaag, PhD., Associate professor and Head of research group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2021

Primary Completion (Actual)

June 15, 2022

Study Completion (Actual)

June 15, 2022

Study Registration Dates

First Submitted

May 5, 2021

First Submitted That Met QC Criteria

May 21, 2021

First Posted (Actual)

May 27, 2021

Study Record Updates

Last Update Posted (Actual)

October 12, 2022

Last Update Submitted That Met QC Criteria

October 10, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2018/2577

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

There is not a plan to make IPD available. The GDPR-regulations make sharing of research data both time-consuming and difficult.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Leg Amputations

Clinical Trials on Rehabilitation Intervention

Subscribe